June 20, 2026
India's obesity drug market expected to exceed $1 billion in two years, analyst says
The company reports up to 71.2 pounds weight loss at 68 weeks during trial
The company’s star weight-loss product Wegovy has been overtaken in the US by rival Eli Lilly’s Zepbound
